Møller Morten Winkler, Andersen Marianne Skovsager, Pedersen Christian Bonde, Kristensen Bjarne Winther, Poulsen Frantz Rom
Department of NeurosurgeryOdense University Hospital, Odense C, Denmark
Clinical InstituteUniversity of Southern Denmark, Odense C, Denmark.
Endocr Connect. 2018 Jul;7(7):897-906. doi: 10.1530/EC-18-0140. Epub 2018 Jul 2.
Intraoperative low field MRI (iMRI, 0.15 T) during transsphenoidal surgery on pituitary adenomas (PAs) may significantly improve tumor removal. However, extensive surgery can lead to pituitary hormone deficiency. Furthermore, introduction of iMRI will prolong duration of surgery, which may elevate risk of postoperative infections.
Overall, 180 transsphenoidal surgeries for PAs from 2007 to 2015 were included. IMRI was available from 2011 to 2015, during this period 67/78 (86%) surgeries were with iMRI (iMRI, = 67). A total of 113 surgeries were performed without iMRI (controls). All surgical procedures were performed by microscopic technique. Tumor size, hormonal status and vision were assessed before surgery and 3-5 months postoperatively.
Gross total resection (GTR), mean tumor remnant volume and ∆-volumes were comparable between iMRI and controls: 15% (10/66) vs 23% (26/109) ( = 0.17), 2.97 cm (0.9-5) vs 2.1 cm (1.6-2.6) ( = 0.3) and 4.5 cm (3.6-5.5) vs 5.1 cm (4.2-6) ( = 0.4), respectively. Duration of surgery was significantly longer during iMRI vs controls: 126 min (117-135) vs 98 min (92-103) ( < 0.001). New pituitary-adrenal deficiency in iMRI vs controls was seen in 35% (17/48) and 35% (23/66) of surgeries, respectively ( = 0.95). New thyroid deficiency was found in 33% (13/29) and 41% (28/69) and visual field deficiencies improved in 44% (19/43) and 38% (23/60) in iMRI vs controls, respectively ( > 0.1).
Tumor remnant after pituitary surgery was not significantly reduced using intraoperative low field MRI. Duration of surgery was increased in iMRI, but was not associated with increased infection rate. Pituitary hormonal function and vision were comparable between iMRI and controls.
垂体腺瘤经蝶窦手术中使用术中低场MRI(iMRI,0.15 T)可显著提高肿瘤切除率。然而,广泛的手术可能导致垂体激素缺乏。此外,引入iMRI会延长手术时间,这可能增加术后感染风险。
共纳入2007年至2015年期间180例垂体腺瘤经蝶窦手术。2011年至2015年可使用iMRI,在此期间67/78(86%)例手术使用了iMRI(iMRI组,n = 67)。共有113例手术未使用iMRI(对照组)。所有手术均采用显微技术。术前及术后3 - 5个月评估肿瘤大小、激素状态和视力。
iMRI组和对照组的全切除率、平均肿瘤残留体积和体积变化相当:分别为15%(10/66)对23%(26/109)(P = 0.17),2.97 cm³(0.9 - 5)对2.1 cm³(1.6 - 2.6)(P = 0.3),4.5 cm³(3.6 - 5.5)对5.1 cm³(4.2 - 6)(P = 0.4)。iMRI组手术时间显著长于对照组:126分钟(117 - 135)对98分钟(92 - 103)(P < 0.001)。iMRI组和对照组分别有35%(17/48)和35%(23/66)的手术出现新的垂体 - 肾上腺功能减退(P = 0.95)。新出现甲状腺功能减退的比例分别为33%(13/29)和41%(28/69),iMRI组和对照组视野缺损改善的比例分别为44%(19/43)和38%(23/60)(P > 0.1)。
垂体手术中使用术中低场MRI并未显著降低肿瘤残留。iMRI组手术时间延长,但与感染率增加无关。iMRI组和对照组的垂体激素功能和视力相当。